This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Financial Results Releases, Succession Plans, And New Appointments To Board Of Directors - Research Report On ResMed, Sirona, Align, ABIOMED, And Globus

NEW YORK, August 7, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting ResMed Inc. (NYSE: RMD), Sirona Dental Systems, Inc. (NASDAQ: SIRO), Align Technology, Inc. (NASDAQ: ALGN), ABIOMED, Inc. (NASDAQ: ABMD), and Globus Medical, Inc. (NYSE: GMED). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

ResMed Inc. Research Report

On August 1, 2013, ResMed, Inc. (ResMed) reported financial results for Q4 FY 2013 and full-year FY 2013. The Company's Q4 FY 2013 revenue was $414.6 million, up 11.5% YoY. Q4 FY 2013 non-GAAP operating income was $110.9 million, up 23.6% YoY, while non-GAAP net income was $90.7 million, up 18.1% YoY. Non-GAAP diluted EPS were $0.62, up 17.0% YoY. For full-year FY 2013, the Company generated revenues of $1.5 billion, up 10.7% YoY; non-GAAP operating income of $379.6 million, up 28.9% YoY; and non-GAAP diluted EPS of $2.22, up 29.8% YoY. Commenting on the results, Mick Farrell, CEO of ResMed said, "In the fourth quarter of fiscal 2013 we showed strong year-over-year growth on both top and bottom lines. We have also announced today that our quarterly dividend has increased by 47% to $0.25 per share. Additionally, during the quarter, we repurchased 1.5 million shares, at a cost of $72.7 million." The Full Research Report on ResMed Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [ http://www.investorsreports.com/report/2013-08-05/RMD]

--

Sirona Dental Systems, Inc. Research Report

On August 2, 2013, Sirona Dental Systems, Inc. (Sirona) announced that its Board of Directors has unanimously approved a succession plan for the CFO of the Company. The Company informed that Ulrich Michel will be joining Sirona as its CFO and Executive Vice President, effective October 14, 2013, and will be succeeding Simone Blank, who will step down as CFO, Executive Vice President, and Board member of the Company. According to Sirona, Michel will be responsible for overseeing and directing all aspects of the financial management of the Company as its CFO and Executive Vice President. Prior to joining Sirona, Michel was the CFO of WABCO for over eight years. The Full Research Report on Sirona Dental Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [ http://www.investorsreports.com/report/2013-08-05/SIRO]

--

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs